−3.45SEK
−177.84 MSEK
5.68 MSEK
28.42 M
About IRLAB THERAPEUTICS AB SER. A
Sector
CEO
Gunnar Olof Olsson
Headquarters
Gothenburg
Website
Employees (FY)
31
Founded
2013
ISIN
SE0012675361
FIGI
BBG00G3F2C80
IRLAB Therapeutics AB engages in the provision of novel treatments for disorders of the brain that focuses on illness in the central nervous system. The fim develops drugs for Parkinson's disease. It also offers IRL752 that targets dementia in Parkinson's disease. The company was founded in 2013 and is headquartered in Gothenburg, Sweden.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of IRLAB_A is 13.20 SEK — it has increased by 3.94% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange IRLAB THERAPEUTICS AB SER. A stocks are traded under the ticker IRLAB_A.
IRLAB THERAPEUTICS AB SER. A is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
IRLAB_A stock is 11.39% volatile and has beta coefficient of −0.02. Check out the list of the most volatile stocks — is IRLAB THERAPEUTICS AB SER. A there?
Yes, you can track IRLAB THERAPEUTICS AB SER. A financials in yearly and quarterly reports right on TradingView.
IRLAB_A stock has fallen by 2.94% compared to the previous week, the month change is a 25.00% fall, over the last year IRLAB THERAPEUTICS AB SER. A has showed a 20.00% increase.
IRLAB_A net income for the last quarter is −34.99 M SEK, while the quarter before that showed −38.39 M SEK of net income which accounts for 8.88% change. Track more IRLAB THERAPEUTICS AB SER. A financial stats to get the full picture.
Today IRLAB THERAPEUTICS AB SER. A has the market capitalization of 658.73 M, it has decreased by 10.86% over the last week.
No, IRLAB_A doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, IRLAB_A shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IRLAB THERAPEUTICS AB SER. A stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 31.00 employees. See our rating of the largest employees — is IRLAB THERAPEUTICS AB SER. A on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So IRLAB THERAPEUTICS AB SER. A technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating IRLAB THERAPEUTICS AB SER. A stock shows the sell signal. See more of IRLAB THERAPEUTICS AB SER. A technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. IRLAB THERAPEUTICS AB SER. A EBITDA is −175.82 M SEK, and current EBITDA margin is −3.10 K%. See more stats in IRLAB THERAPEUTICS AB SER. A financial statements.